title: Evidence for an important role of CIDEA in human cancer cachexia.
abstract: Loss of fat mass in cancer cachexia is linked to increased adipocyte lipolysis; however, the fate of the excess fatty acids (FA) generated by lipolysis is not known. We investigated if the adipocyte-specific gene cell death-inducing DNA fragmentation factor-alpha-like effector A (CIDEA) could be involved. CIDEA mRNA expression was assessed in s.c. white adipose tissue from 23 cancer cachexia patients, 17 weight-stable cancer patients, and 8 noncancer patients. CIDEA was also overexpressed in adipocytes in vitro. CIDEA expression was increased in cancer cachexia (P < 0.05) and correlated with elevated levels of FAs and reported weight loss (P < 0.001). CIDEA overexpression in vitro increased FA oxidation 2- to 4-fold (P < 0.01), decreased glucose oxidation by 40% (P < 0.01), increased the expression of pyruvate dehydrogenase kinase (PDK) 1 and PDK4 (P < 0.01), and enhanced the phosphorylation (inactivation) of the pyruvate dehydrogenase complex (PDC). Inactivation of PDC facilitates FA oxidation by favoring the metabolism of FAs over glucose to acetyl-CoA. In accordance with the in vitro data, PDK1 and PDK4 expression correlated strongly with CIDEA expression in white adipose tissue (P < 0.001). We conclude that CIDEA is involved in adipose tissue loss in cancer cachexia and this may, at least in part, be due to its ability to inactivate PDC, thereby switching substrate oxidation in human fat cells from glucose to FAs.
authors.affiliation: Department of Medicine, Karolinska Institutet, Karolinska University Hospital, Huddinge, Stockholm, Sweden.
authors.forename: Jurga
authors.initials: J
authors.lastname: Laurencikiene
authors.forename: Britta M
authors.initials: BM
authors.lastname: Stenson
authors.forename: Elisabet
authors.initials: E
authors.lastname: Arvidsson Nordström
authors.forename: Thorhallur
authors.initials: T
authors.lastname: Agustsson
authors.forename: Dominique
authors.initials: D
authors.lastname: Langin
authors.forename: Bengt
authors.initials: B
authors.lastname: Isaksson
authors.forename: Johan
authors.initials: J
authors.lastname: Permert
authors.forename: Mikael
authors.initials: M
authors.lastname: Rydén
authors.forename: Peter
authors.initials: P
authors.lastname: Arner
mesh_terms: D041721:3T3-L1 Cells; D017667:Adipocytes / Q000378:metabolism; D052436:Adipose Tissue, White / Q000378:metabolism; D000328:Adult; D000368:Aged; D000818:Animals; D051017:Apoptosis Regulatory Proteins / Q000235:genetics / Q000502:physiology*; D015992:Body Mass Index; D002100:Cachexia / Q000209:etiology*; D004734:Energy Metabolism; D005227:Fatty Acids / Q000378:metabolism; D005260:Female; D005947:Glucose / Q000378:metabolism; D006801:Humans; D008297:Male; D051379:Mice; D008875:Middle Aged; D009369:Neoplasms / Q000150:complications*; D010766:Phosphorylation; D017346:Protein Serine-Threonine Kinases / Q000235:genetics; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism; D012333:RNA, Messenger / Q000032:analysis
chemical_list: D051017:Apoptosis Regulatory Proteins; C502539:CIDEA protein, human; D005227:Fatty Acids; C000631429:PDK1 protein, human; C000631432:PDK4 protein, human; C000631433:Pdk1 protein, mouse; C000631439:Pdk4 protein, mouse; D000081382:Pyruvate Dehydrogenase Acetyl-Transferring Kinase; D011768:Pyruvate Dehydrogenase Complex; D012333:RNA, Messenger; D017346:Protein Serine-Threonine Kinases; D005947:Glucose